The 3D cell culture market is experiencing robust growth, driven by advancements in cell-based research and increasing governmental funding for biotechnology and regenerative medicine. According to the latest statistics from the U.S. National Institutes of Health (NIH), federal funding for stem cell research surpassed $2 billion in 2023, reflecting a 10% increase compared to 2022. Similarly, the European Commission allocated over €1.8 billion in 2023 under Horizon Europe’s health cluster, emphasizing regenerative medicine and tissue engineering. In parallel, the Indian Department of Biotechnology announced a 15% increase in funding, earmarking over ₹500 crore for tissue engineering projects in its 2023–24 fiscal budget.